Spina bifida and other spinal dysraphisms
ORPHA:823CategoryMultigenic/multifactorial, Not applicableInfancy, Neonatal
Эпидемиология22
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 1-5 / 10 000 | 18.6 | Europe | Value and class |
| Point prevalence | 1-5 / 10 000 | — | Europe | Class only |
| Point prevalence | 1-5 / 10 000 | 50 | France | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 24.8 | United States | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 9.8 | Austria | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 17.5 | Belgium | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 11.4 | Croatia | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 21.3 | Denmark | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 19.6 | France | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 17.8 | Germany | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 14.4 | Hungary | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 50.6 | Ireland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 12.7 | Italy | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 24.9 | Malta | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 17.5 | Netherlands | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 14.7 | Norway | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 24.4 | Poland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 18.9 | Portugal | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 5 | Spain | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 12.6 | Switzerland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 13.1 | United Kingdom | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 41.3 | Ukraine | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)